-
Drugs
-
Antidepressant Use in Children, Adolescents, and Adults
The U.S. Food and Drug Administration (FDA) today proposed that makers of all antidepressant medications update the existing black box warning on their products' labeling to include warnings about increased risks of suicidal thinking and behavior, known as suicidality, in young adults ages 18 to 24 during initial treatment (generally the first one to two months).
Current Information
- FDA News
- Medication Guide for Antidepressant Drugs (PDF - 27KB)
- Revisions to Product Labeling (PDF - 28KB)
- Questions and Answers
List of Antidepressant Drugs with Medication Guides
| Anafranil (clomipramine) Asendin (amoxapine) Aventyl (nortriptyline) Celexa (citalopram hydrobromide) Cymbalta (duloxetine) Desyrel (trazodone HCl) Elavil (amitriptyline) Effexor (venlafaxine HCl) Emsam (selegiline) Etrafon (perphenazine/amitriptyline) fluvoxamine maleate Lexapro (escitalopram oxalate) Limbitrol (chlordiazepoxide/amitriptyline) Ludiomil (maprotiline) Marplan (isocarboxazid) Nardil (phenelzine sulfate) nefazodone HCl Norpramin (desipramine HCl) |
Pamelor (nortriptyline) Parnate (tranylcypromine sulfate) Paxil (paroxetine HCl) Pexeva (paroxetine mesylate) Prozac (fluoxetine HCl) Remeron (mirtazapine) Sarafem (fluoxetine HCl) Seroquel (quetiapine) Sinequan (doxepin) Surmontil (trimipramine) Symbyax (olanzapine/fluoxetine) Tofranil (imipramine) Tofranil-PM (imipramine pamoate) Triavil (perphenazine/amitriptyline) Vivactil (protriptyline) Wellbutrin (bupropion HCl) Zoloft (sertraline HCl) Zyban (bupropion HCl) |
For more information on some of these drugs, please see the Index to Drug-Specific Information.
-
-